The role of inflammation in CNS injury and disease
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
For many years, the central nervous system (CNS) was considered to be ‘immune privileged’, neither susceptible to nor contributing to inflammation. It is now appreciated that the CNS does exhibit features of inflammation, and in response to injury, infection or disease, resident CNS cells generate inflammatory mediators, including proinflammatory cytokines, prostaglandins, free radicals and complement, which in turn induce chemokines and adhesion molecules, recruit immune cells, and activate glial cells. Much of the key evidence demonstrating that inflammation and inflammatory mediators contribute to acute, chronic and psychiatric CNS disorders is summarised in this review. However, inflammatory mediators may have dual roles, with detrimental acute effects but beneficial effects in long‐term repair and recovery, leading to complications in their application as novel therapies. These may be avoided in acute diseases in which treatment administration might be relatively short‐term. Targeting interleukin (IL)‐1 is a promising novel therapy for stroke and traumatic brain injury, the naturally occurring antagonist (IL‐1ra) being well tolerated by rheumatoid arthritis patients. Chronic disorders represent a greater therapeutic challenge, a problem highlighted in Alzheimer's disease (AD); significant data suggested that anti‐inflammatory agents might reduce the probability of developing AD, or slow its progression, but prospective clinical trials of nonsteroidal anti‐inflammatory drugs or cyclooxygenase inhibitors have been disappointing. The complex interplay between inflammatory mediators, ageing, genetic background, and environmental factors may ultimately regulate the outcome of acute CNS injury and progression of chronic neurodegeneration, and be critical for development of effective therapies for CNS diseases. British Journal of Pharmacology (2006) 147, S232–S240. doi:10.1038/sj.bjp.0706400
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As various neurological and psychiatric diseases have been associated with neuroinflammation in some post-mortem studies,183, 184, 185”
From Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review (2018) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Stroke is caused by ischaemia, leading to inflammation [900] and to the formation of ROS and other damaging free radicals [901] in the brain”
The cited source says what the claim attributes to it.
In the citing paper
“These processes induce adhesion molecules and, in order, mobilize immune and glial cells in a parallel and synergistic way (94, 126 -128).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [127]
In the citing paper
“Thus, although this is not the focus of the present more physiologically based review, we recognise that many of relationships between ROSs and oxidative stress and overt progressive diseases may be mediated via the inflammatory signalling pathways involved in 'innate immunity' [900,1991-1993].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury
Faulkner, J. R., Herrmann, J. E., Woo, M. J., Tansey, K. E., Doan, N. B., & Sofroniew, M. V. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3547-03.2004 · Cited by 1,598 · cited 1×
“…for repair and recovery, but in fact this increases neuronal loss from the injury site and inhibits repair of the BBB and axonal remyelination (Faulkner et al., 2004), partly because astrocytes produce neurotrophic factors such as nerve growth factor and brain-derived growth factor that are…”
BackgroundMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · cited 1×
“Although other epidemiological studies also suggest a beneficial role for antiinflammatory agents in AD (McGeer et al., 1996), the general view from prospective trials of nonsteroidal inflammatory drugs (NSAIDs) is that they are disappointingly variable.”
BackgroundTNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
Interleukin 1 in the brain: biology, pathology and therapeutic target
Rothwell, N. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01661-1 · Cited by 671 · cited 3×
“IL-1 was discovered as an important endogenous pyrogen, and is now recognised as the ‘prototypic inflammatory cytokine’ (reviewed by Rothwell & Luheshi, 2000).”
BackgroundInfluentialSelf-citationPerry, V. H. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.01.004 · Cited by 560 · cited 2×
“…metalloproteinase and iNOS activities, and breakdown of the BBB. Complications of its use however include inhibition of remyelination in MS models, and observations that microglial activation may be associated with anti-inflammatory cytokine expression rather than proinflammatory (Perry, 2004).”
BackgroundInflammation and the Degenerative Diseases of Aging
McGEER, P. L., & McGEER, E. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.007 · Cited by 518 · cited 1×
“The complement cascade is activated, and mRNAs for complement proteins are upregulated in PD (and AD) to a greater extent than in peripheral inflammatory diseases such as rheumatoid arthritis (reviewed by McGeer & McGeer, 2004).”
BackgroundScherbel, U., Raghupathi, R., Nakamura, M., Saatman, K. E., Trojanowski, J. Q., Neugebauer, E., Marino, M. W., & McIntosh, T. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8721 · Cited by 415 · cited 1×
“…injury, the TNFa knockout mice show less behavioural impairment than the wild-type controls, but while the wild-type mice recovered in the weeks following injury, the knockout mice did not, remaining significantly impaired both in terms of histological damage and behaviour (Scherbel et al., 1999).”
BackgroundNew Insights into the Biology of the Acute Phase Response
Suffredini, A. F., Fantuzzi, G., Badolato, R., Oppenheim, J. J., & O'Grady, N. P. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020563913045 · Cited by 391 · cited 1×
“This represents another host defence mechanism which can limit proliferation of invading pathogens (Suffredini et al., 1999).”
BackgroundVezzani, A., Moneta, D., Richichi, C., Aliprandi, M., Burrows, S. J., Ravizza, T., Perego, C., & De Simoni, M. G. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.5.14.x · Cited by 386 · cited 1×
“Exogenous IL-1b enhances chemically induced seizures in rats and IL-1ra inhibits motor seizures and delays their onset (see Vezzani et al., 2002).”
Background
Cited by
Pathophysiology of traumatic brain injury
Werner, C., & Engelhard, K. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/aem131 · Cited by 1,712
Nita, M., & Grzybowski, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3164734 · Cited by 1,448
“Apoptotic processes are also activated by microglial cells, which release inflammatory mediators (cytokines, prostaglandins, and complement molecules) and reactive oxygen species [113].”
BackgroundInflammatory mechanisms in ischemic stroke: therapeutic approaches
Lakhan, S. E., Kirchgessner, A., & Hofer, M. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-97 · Cited by 1,072
“There is substantial evidence that activated microglial cells in response to ischemia have the potential of releasing several pro-inflammatory cytokines such as TNFα, IL-1β, and IL-6, as well as other potential cytotoxic molecules including NO, ROS, and prostanoids [25].”
IL‐1, IL‐18, and IL‐33 families of cytokines
Arend, W. P., Palmer, G., & Gabay, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00624.x · Cited by 912
“Diseases of the central nervous system An extensive literature exists on the production of IL-1b by microglial and other cells in the brain, primarily in the hypothalamus (50, 51).”
BackgroundBlood–brain barrier breakdown as a therapeutic target in traumatic brain injury
Shlosberg, D., Benifla, M., Kaufer, D., & Friedman, A. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.74 · Cited by 897
Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery
Cramer, S. C. (2008) · Annals of Neurology · doi:10.1002/ana.21393 · Cited by 875
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke
Yang, C., Hawkins, K. E., Doré, S., & Candelario-Jalil, E. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00136.2018 · Cited by 871
“Following injury, microglia are activated and migrate to the damaged area where they can release proinflammatory cytokines such as IL-1 , TNF- , and IL-6, as well as other potential cytotoxic molecules, including NO, ROS, and prostaglandins (127).”
BackgroundInflammatory caspases and inflammasomes: master switches of inflammation
Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402038 · Cited by 820
“Similarly, IL-1b may be toxic for neurons and is involved in acute neurodegeneration and stroke.(29) Although many important biological effects of IL-1b are well described, key questions remain unresolved about the mechanism by which the production of this cytokine is regulated.”
BackgroundLeonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
Ziebell, J. M., & Morganti-Kossmann, M. C. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2009.10.016 · Cited by 667
“The inflammatory cascade activated after TBI is mediated by the release of pro- and anti-inflammatory cytokines, which are polypeptides, normally barely detectable in healthy tissue but rapidly upregulated in response to pathological or stressful challenges.(11,16) Besides their involvement in immune processes, cytoki…”
BackgroundPurinergic signalling and disorders of the central nervous system
Burnstock, G. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2605 · Cited by 634
“The CNS can undergo all the typical changes induced by inflammation, activate endogenous inflammatory cells and generate inflammatory mediator”
BackgroundInflammation as a causative factor in the aetiology of Parkinson's disease
Whitton, P. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707167 · Cited by 624
“prostaglandins and cytokines, which cause further disease progression (Arai et al., 2004, 2006; Lucas et al., 2006).”
BackgroundPathogenic mechanisms following ischemic stroke
Khoshnam, S. E., Winlow, W., Farzaneh, M., Farbood, Y., & Moghaddam, H. F. (2017) · Neurological Sciences · doi:10.1007/s10072-017-2938-1 · Cited by 621
Kaempferol and inflammation: from chemistry to medicine
Devi, K. P., Malar, D. S., Nabavi, S. F., Sureda, A., Xiao, J., Nabavi, S. M., & Daglia, M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.05.002 · Cited by 619
Epilepsy and brain inflammation
Vezzani, A., Aronica, E., Mazarati, A., & Pittman, Q. J. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.033 · Cited by 603
“Finally, brain inflammation may contribute to BBB breakdown and to the consequent parenchymal accumulation of serum albumin and IgG.”
InfluentialPivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage
Alfonso-Loeches, S., Pascual-Lucas, M., Blanco, A. M., Sanchez-Vera, I., & Guerri, C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0976-10.2010 · Cited by 579
“The hallmark of brain inflammation is the activation of glial cells, primarily microglia and astrocytes, that release free radicals, cytokines, and inflammatory mediators, which can induce brain damage (Lucas et al., 2006).”
BackgroundHopperton, K. E., Mohammad, D., Trépanier, M. O., Giuliano, V, & Bazinet, R. P. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.246 · Cited by 622
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“[900] and to the formation of ROS and other damaging”
BackgroundBramlett, H. M., & Dietrich, W. D. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2014.3352 · Cited by 550
Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway
Zusso, M., Lunardi, V., Franceschini, D., Pagetta, A., Lo, R., Stifani, S., Frigo, A. C., Giusti, P., & Moro, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1538-9 · Cited by 534
“activity results in an inappropriate immune response that can lead to tissue damage and affect CNS functions [2].”
BackgroundInflammatory Neurodegeneration and Mechanisms of Microglial Killing of Neurons
Brown, G. C., & Neher, J. J. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8105-9 · Cited by 528
“These pathologies have different causes and consequences, but they all involve brain inflammation, and there is evidence that blocking inflammation can either delay onset or reduce symptoms [1-6].”
BackgroundWe Care, Therefore We Are: Anesthesia-related Morbidity and Mortality
Cottrell, J. E. (2008) · Anesthesiology · doi:10.1097/aln.0b013e31818344da · Cited by 515
“The ensuing cascade of events ultimately affects the anesthetic -aminobutyric acid and N-methylD-aspartic acid receptors and increases production of -amyloid, and we know that -amyloid, even in nondemented patients, can cause cognitive problems if there is enough of it.(41) Genetic predispositions are another aggravat…”
BackgroundAcylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Dambrova, M., Makrecka-Kuka, M., Kuka, J., Vilskersts, R., Nordberg, D., Attwood, M. M., Smesny, S., Sen, Z. D., Guo, A. C., Oler, E., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000408 · Cited by 507
“In general, the pathogenesis of many CNS-related disorders involves mitochondrial dysfunction and inflammation (Lucas et al., 2006; Golpich et al., 2017; Skaper et al., 2018).”
BackgroundSex differences in Parkinson’s disease
Gillies, G. E., Pienaar, I. S., Vohra, S., & Qamhawi, Z. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.02.002 · Cited by 489
“In the early, activation stage of the innate immune response, microglia and to a lesser extent, the astrocytes, produce oxidative and pro-inflammatory (potentially harmful) mediators; this triggers the later, resolution phase of the immune response, involving production of anti-inflammatory (protective) factors as wel…”
BackgroundAnti-Inflammatory Activity of Natural Products
Azab, A., Nassar, A., & Azab, A. (2016) · Molecules · doi:10.3390/molecules21101321 · Cited by 462
“Inflammation may also happen in response to processes such as tissue injury, cell death, cancer, ischemia and degeneration [1,4–9].”
BackgroundAstaxanthin: A mechanistic review on its biological activities and health benefits
Fakhri, S., Abbaszadeh, F., Dargahi, L., & Jorjani, M. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.012 · Cited by 461
“Inflammation plays a significant role in both acute and chronic neurodegenerative conditions [75].”
BackgroundModulation of inflammation in brain: A matter of fat
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04371.x · Cited by 460
Muneer, P. M. A., Chandra, N., & Haorah, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8752-3 · Cited by 459
“the brain with oxidative stress and MMPs to cause delayed recovery [126, 127].”
Recent Advances in Pathophysiology of Traumatic Brain Injury
Kaur, P., & Sharma, S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170613083606 · Cited by 444
“The progression of tissue damage is related to direct discharge of neurotoxic mediators or indirectly to the release of nitric oxide and cytokines [104].”
InfluentialKubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J., & Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.026 · Cited by 443
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
Kapadia, R. (2008) · Frontiers in Bioscience · doi:10.2741/2802 · Cited by 433
Diamond, L. M., & Alley, J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104720 · Cited by 412
Modulation of immune response by head injury
Morganti-Kossmann, M. C., Satgunaseelan, L., Bye, N., & Kossmann, T. (2007) · Injury · doi:10.1016/j.injury.2007.10.005 · Cited by 412
The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases
Conductier, G., Blondeau, N., Guyon, A., Nahon, J.-L., & Rovère, C. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.010 · Cited by 404
Zhang, R., Liu, Y., Yan, K., Chen, L., Chen, X.-R., Li, P., Chen, F.-F., & Jiang, X.-D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-106 · Cited by 391
“Moreover, activated microglia migrate to injured sites and release cytokines, chemotactic cytokines, reactive oxygen species, nitric oxide, proteases and other factors with cytotoxic effects, which may in turn exacerbate neuronal death [6,8].”
BackgroundMicroglial Activation in Stroke: Therapeutic Targets
Yenari, M. A., Kauppinen, T. M., & Swanson, R. A. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.005 · Cited by 389
“altered after ischemia.(56) These factors function primarily as intercellular signaling molecules, and many have feedforward effects in driving the inflammatory response.”
BackgroundImmune interventions in stroke
Fu, Y., Liu, Q., Anrather, J., & Shi, F.-D. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.144 · Cited by 383
Neuroinflammation and regulation of glial glutamate uptake in neurological disorders
Tilleux, S., & Hermans, E. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21325 · Cited by 381
“Indeed, although peripheral inflammation involves tissue swelling, redness, local heat, and pain, the central neuroinflammation response has distinctive features (Lucas et al., 2006).”
BackgroundKempuraj, D., Thangavel, R., Selvakumar, G. P., Zaheer, S., Ahmed, M. E., Raikwar, S. P., Zahoor, H., Saeed, D., Natteru, P. A., Iyer, S., et al. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00216 · Cited by 365
“On the one side, neuroinflammation induces and/or aggravates neurodegeneration in the central nervous system (CNS), while on the other side, it favors the recovery of the injured neurons (Lucas et al., 2006).”
BackgroundNeuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
Rojo, L. E., Fernández, J. A., Maccioni, A. A., Jimenez, J. M., & Maccioni, R. B. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.10.001 · Cited by 351
“It has also been demonstrated that PPARg agonists such as thiazolidinediones reverted Ab-stimulated microglial activation, secretion of proinflammatory products, and microglial-mediated astrocyte proliferation, IL-6 (159).”
BackgroundCeulemans, A.-G., Zgavc, T., Kooijman, R., Hachimi-Idrissi, S., Sarre, S., & Michotte, Y. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-74 · Cited by 351
“Stroke and neurodegenerative diseases such as Alzheimer’s disease, multiple sclerosis and Parkinson’s disease are associated with a chronic inflammatory response [2,3].”
BackgroundLevesque, S., Surace, M. J., McDonald, J., & Block, M. L. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-105 · Cited by 340
“IL-1b is another pro-inflammatory factor elevated in PD and AD that has been widely implicated in neuronal damage [50].”
BackgroundANISMAN, H., MERALI, Z., & HAYLEY, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 337
“, attenuating the effects of the endogenous IL-1 receptor antagonist) markedly exacerbated neuronal damage (Loddick et al., 1997; Lucas et al., 2006).”
Multiple Roles for Astrocytes as Effectors of Cytokines and Inflammatory Mediators
Sofroniew, M. V. (2014) · The Neuroscientist · doi:10.1177/1073858413504466 · Cited by 333
Anti-Inflammatory Treatments for Chronic Diseases: A Review
Laveti, D., Kumar, M., Hemalatha, R., Sistla, R., Naidu, V., Talla, V., Verma, V., Kaur, N., & Nagpal, R. (2013) · Inflammation & Allergy-Drug Targets · doi:10.2174/18715281113129990053 · Cited by 325
“Different inflammatory markers like TNF- , IL-1, IL-6 and prostaglandins have been detected as targets in support of different CNS disorders such as stroke, traumatic brain injury, epilepsy, multiple sclerosis, Alzheimer’s disease, schizophrenia, depression and Parkinsonism [87].”
BackgroundAbulafia, D. P., de Rivero Vaccari, J. P., Lozano, J. D., Lotocki, G., Keane, R. W., & Dietrich, W. D. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.143 · Cited by 322
“…to cerebral infarction promotes a cascade of inflammatory processes initiated by endothelial dysfunction, blood–brain barrier disruption, brain edema, and the expression Journal of Cerebral Blood Flow & Metabolism (2009) 29, 534–544 of a variety of inflammatory mediators (Lucas et al, 2006).”
BackgroundMechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase
Brown, G. C. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351119 · Cited by 316
Brown, G. C., & Vilalta, A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.08.031 · Cited by 311
Salim, S., Chugh, G., & Asghar, M. (2012) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/b978-0-12-398314-5.00001-5 · Cited by 310
Contributions of peripheral inflammation to seizure susceptibility: Cytokines and brain excitability
Riazi, K., Galic, M. A., & Pittman, Q. J. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.09.004 · Cited by 306
Qin, L., & Crews, F. T. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-5 · Cited by 290
“Activation of glial cells, especially microglia, that release pro-inflammatory factors and reactive oxygen species (ROS) have been implicated in several models of neurodegeneration [16,17].”
BackgroundInterleukin-1 and inflammatory neurodegeneration
Simi, A., Tsakiri, N., Wang, P., & Rothwell, N. J. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351122 · Cited by 288
Self-citationTaylor, A. G., Goehler, L. E., Galper, D. I., Innes, K. E., & Bourguignon, C. (2010) · EXPLORE · doi:10.1016/j.explore.2009.10.004 · Cited by 287
“Chronic inflammation is involved in the pathophysiology of many diseases, including heart disease, diabetes, autoimmunity, allergy, inflammatory bowel diseases, neurodegenerative disease, stroke, and epilepsy (104).”
Repairing the human brain after stroke. II. Restorative therapies
Cramer, S. C. (2008) · Annals of Neurology · doi:10.1002/ana.21412 · Cited by 285
“Similarly, therapies that modulate inflammation are likely time sensitive given that inflammatory mediators can have detrimental effects acutely but beneficial effects later during repair.(176,177)”
BackgroundNew perspectives on central and peripheral immune responses to acute traumatic brain injury
Das, M., Mohapatra, S., & Mohapatra, S. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-236 · Cited by 281
“The complex nature of acute and chronic inflammatory reactions may aggravate the pathologic outcome or promote the repair process [16,17].”
BackgroundAge and energy intake interact to modify cell stress pathways and stroke outcome
Arumugam, T. V., Phillips, T. M., Cheng, A., Morrell, C. H., Mattson, M. P., & Wan, R. (2010) · Annals of Neurology · doi:10.1002/ana.21798 · Cited by 281
Stress as a neuroinflammatory condition in brain: Damaging and protective mechanisms
García-Bueno, B., Caso, J. R., & Leza, J. C. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.04.001 · Cited by 280
In Situ Detection of Inflammatory Mediators in Post Mortem Human Brain Tissue after Traumatic Injury
Frugier, T., Morganti-Kossmann, M. C., O'Reilly, D., & McLean, C. A. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1120 · Cited by 278
The spleen contributes to stroke‐induced neurodegeneration
Ajmo, C. T., Vernon, D. O. L., Collier, L., Hall, A. A., Garbuzova‐Davis, S., Willing, A., & Pennypacker, K. R. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21661 · Cited by 272
“Microglia, infiltrating macrophages, and neutrophils all enhance neuroinflammation at the site of ischemia (Barone et al., 1995; Barone and Feuerstein, 1999; Allan and Rothwell, 2003; Lucas et al., 2006).”
Fillman, S. G., Weickert, T. W., Lenroot, R. K., Catts, S. V., Bruggemann, J. M., Catts, V. S., & Weickert, C. S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.90 · Cited by 270
Bai, J., & Lyden, P. D. (2015) · International Journal of Stroke · doi:10.1111/ijs.12434 · Cited by 270
Kölliker-Frers, R., Udovin, L., Otero-Losada, M., Kobiec, T., Herrera, M. I., Palacios, J., Razzitte, G., & Capani, F. (2021) · Mediators of Inflammation · doi:10.1155/2021/9999146 · Cited by 258
“Together with the interferon-gamma protein (IFN-γ), TNF-α is proinflammatory during acute brain inflammation and is immunosuppressive upon chronicity [67].”
Treweek, J. B., Chan, K. Y., Flytzanis, N. C., Yang, B., Deverman, B. E., Greenbaum, A., Lignell, A., Xiao, C., Cai, L., Ladinsky, M. S., et al. (2015) · Nature Protocols · doi:10.1038/nprot.2015.122 · Cited by 258
Molecular and behavioral aspects of the actions of alcohol on the adult and developing brain
Alfonso-Loeches, S., & Guerri, C. (2011) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.580567 · Cited by 254
Prevention and treatment of drug addiction by environmental enrichment
Solinas, M., Thiriet, N., Chauvet, C., & Jaber, M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.08.002 · Cited by 253
Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia
Lehnardt, S., Lehmann, S., Kaul, D., Tschimmel, K., Hoffmann, O., Cho, S., Krueger, C., Nitsch, R., Meisel, A., & Weber, J. R. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.07.023 · Cited by 252
“However, it has become evident that inflammation in the CNS also contributes to neuronal injury and exacerbates tissue injury (Lucas et al., 2006).”
BackgroundImmunity and Inflammation in Epilepsy
Vezzani, A., Lang, B., & Aronica, E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022699 · Cited by 247
“Cite this article as Cold Spring Harb Perspect Med 2016;6:a022699 7 w w w .p er sp ec ti ve si n m ed ic in e. o rg view, see Lucas et al. 2006).”
BackgroundExosome‐mediated inflammasome signaling after central nervous system injury
de Rivero Vaccari, J. P., Brand, F., Adamczak, S., Lee, S. W., Perez‐Barcena, J., Wang, M. Y., Bullock, M. R., Dietrich, W. D., & Keane, R. W. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13036 · Cited by 240
Akhtar, A., Andleeb, A., Waris, T. S., Bazzar, M., Moradi, A.-R., Awan, N. R., & Yar, M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.021 · Cited by 240
O’Connor, J. C., McCusker, R. H., Strle, K., Johnson, R. W., Dantzer, R., & Kelley, K. W. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2007.09.010 · Cited by 238
“However, proinflammatory cytokines can also promote neurodegeneration, excitotoxicity and accentuate ischemic injury [129–131].”
BackgroundInflammatory Aspects of Alzheimer Disease and Other Neurodegenerative Disorders
Schwab, C., & McGeer, P. L. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13402 · Cited by 234
“IL-1RA is being tested in a Phase II trial in stroke patients [43,74].”
Hamby, M. E., Coppola, G., Ao, Y., Geschwind, D. H., Khakh, B. S., & Sofroniew, M. V. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1256-12.2012 · Cited by 228
“Both inflammation and reactive astrogliosis are features of many CNS disorders including stroke, trauma, neurodegeneration, infection, and autoimmunity (Lucas et al., 2006; Barres, 2008; Sofroniew and Vinters, 2010), yet how their interactions influence one another is not well understood.”
BackgroundKesarwani, P., Murali, A. K., Al-Khami, A. A., & Mehrotra, S. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4073 · Cited by 226
“Several studies present evidence that activated microglial cells, in response to ischemia, have the potential to release several proinflammatory cytokines such as TNF-a, IL-1b, and IL-6, as well as other potential cytotoxic molecules, including NO and ROS (167).”
BackgroundComplement activation in experimental and human temporal lobe epilepsy
Aronica, E., Boer, K., van Vliet, E. A., Redeker, S., Baayen, J. C., Spliet, W. G. M., van Rijen, P. C., Troost, D., Lopes da Silva, F. H., Wadman, W. J., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.01.015 · Cited by 226
Azam, S., Jakaria, M., Kim, I.-S., Kim, J., Haque, M. E., & Choi, D.-K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01000 · Cited by 226
Yanguas‐Casás, N., Barreda‐Manso, M. A., Nieto‐Sampedro, M., & Romero‐Ramírez, L. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25742 · Cited by 223
Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions
Jarrahi, A., Braun, M., Ahluwalia, M., Gupta, R. V., Wilson, M., Munie, S., Ahluwalia, P., Vender, J. R., Vale, F. L., Dhandapani, K. M., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8100389 · Cited by 223
“In response, astrocytes, microglia, and neurons at the injury site begin secreting cytokines and chemokines [191,197].”
BackgroundInterleukin-1β impairs brain derived neurotrophic factor-induced signal transduction
Tong, L., Balazs, R., Soiampornkul, R., Thangnipon, W., & Cotman, C. W. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.027 · Cited by 222
“Accumulating evidence suggests that proinflammatory cytokines play important roles in CNS injury and neurodegenerative diseases, including Alzheimer's disease (AD)[22, 37].”
BackgroundPituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1065 · Cited by 218
NALP Inflammasomes: a central role in innate immunity
Martinon, F., Gaide, O., Pétrilli, V., Mayor, A., & Tschopp, J. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0079-y · Cited by 218
“IL-1β also plays a role in destructive joint and bone diseases and displays toxicity for insulin-producing β-cells in islets of Langerhans [88, 140] and neurons, where it is involved in acute neurodegeneration and stroke [86].”
BackgroundThe Role of Selected Pro-Inflammatory Cytokines in Pathogenesis of Ischemic Stroke
Pawluk, H., Woźniak, A., Grześk, G., Kołodziejska, R., Kozakiewicz, M., Kopkowska, E., Grzechowiak, E., & Kozera, G. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s233909 · Cited by 218
Oxidative Stress in Traumatic Brain Injury
Fesharaki-Zadeh, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113000 · Cited by 217
Gałecki, P., Szemraj, J., Bieńkiewicz, M., Florkowski, A., & Gałecka, E. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70084-2 · Cited by 214
“Psychological and physical stress, both common in depression, activate these cells [45].”
BackgroundChen, S., Dong, Z., Cheng, M., Zhao, Y., Wang, M., Sai, N., Wang, X., Liu, H., Huang, G., & Zhang, X. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0963-x · Cited by 214
“In contrast, overactivated microglia following ischemia stroke can secrete a wide range of inflammatory factors and neurotoxic compounds, including nitric oxide, tumor necrosis factor (TNF)-α, interleukin (IL)-6, and reactive oxygen species (ROS), which are deleterious to bystander neurons and impact their processes […”
BackgroundRaging the War Against Inflammation With Natural Products
Attiq, A., Jalil, J., Husain, K., & Ahmad, W. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00976 · Cited by 211
“Autoimmune Diseases Several pharmacological studies conducted on eicosanoids have given the genetic evidence of PGs and COX-2, in development of autoimmune diseases including rheumatoid arthritis (RA) (Minghetti, 2004; Lucas et al., 2006).”
BackgroundBoer, K., Jansen, F., Nellist, M., Redeker, S., van den Ouweland, A. M. W., Spliet, W. G. M., van Nieuwenhuizen, O., Troost, D., Crino, P. B., & Aronica, E. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2007.10.002 · Cited by 210
Biological role of Toll-like receptor-4 in the brain
Trotta, T., Porro, C., Calvello, R., & Panaro, M. A. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.01.014 · Cited by 207
“brain injury following TBI (Wang et al., 2000; Lucas et al., 2006).”
Cazareth, J., Guyon, A., Heurteaux, C., Chabry, J., & Petit-Paitel, A. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-132 · Cited by 206
“Indeed, in response to infection or injury, the brain exhibits many hallmarks of inflammation such as edema, activation of brain mononuclear phagocytes (microglia and macrophages), local invasion of circulating immune cells, and production of cytokines (for review, see [24]).”
BackgroundTraumatic brain injury, neuroimaging, and neurodegeneration
Bigler, E. D. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00395 · Cited by 204
“…regardless of their nature, would likely interact with the aging process and may set the stage for adverse neuropsychiatric and neurocognitive outcome after injury along with increased risk for age-related neurodegenerative diseases (Lucas et al., 2006; Johnson et al., 2012; Shively et al., 2012).”
BackgroundAcute Lung Injury in Patients with Severe Brain Injury: A Double Hit Model
Mascia, L. (2009) · Neurocritical Care · doi:10.1007/s12028-009-9242-8 · Cited by 202
“The brain was for many years regarded as an ‘‘immune privileged’’ organ, which was not susceptible to inflammation or immune activation and was thought to be largely unaffected by systemic inflammatory and immune responses; however, this view has recently been re-assessed [21].”
BackgroundCirculating Cytokines as Biomarkers of Alcohol Abuse and Alcoholism
Achur, R. N., Freeman, W. M., & Vrana, K. E. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9185-z · Cited by 200
“Thus, increased post-ictal serum cytokine levels in patients with seizure disorders could be used as biomarkers for detection (Sinha et al. 2008), which is in agreement with earlier studies (Lucas et al. 2006).”
BackgroundResultInfluentialInflammation and prevention of epileptogenesis
Ravizza, T., Balosso, S., & Vezzani, A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.040 · Cited by 199
Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases
Wu, H., Niu, H., Shao, A., Wu, C., Dixon, B., Zhang, J., Yang, S., & Wang, Y. (2015) · Marine Drugs · doi:10.3390/md13095750 · Cited by 199
“, AD, PD, and HD) [66].”
Caso, J. R., Pradillo, J. M., Hurtado, O., Leza, J. C., Moro, M. A., & Lizasoain, I. (2008) · Stroke · doi:10.1161/strokeaha.107.498212 · Cited by 193
Cellular and Molecular Pathophysiology of Traumatic Brain Injury: What Have We Learned So Far?
Freire, M. A. M., Rocha, G. S., Bittencourt, L. O., Falcão, D., Lima, R. R., & Cavalcanti, J. R. L. D. P. (2023) · Biology · doi:10.3390/biology12081139 · Cited by 194
“TNF-α, in particular, has an important role during the acute inflammatory process, since it induces the expression of IL-1 and IL-6; IL-1, in turn, induces both TNF-α and IL-6.”
BackgroundInfluentialNi, H., Yang, S., Siaw-Debrah, F., Hu, J., Wu, K., He, Z., Yang, J., Pan, S., Lin, X., Ye, H., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00014 · Cited by 191
New therapeutic perspectives to manage refractory immune checkpoint-related toxicities
Martins, F., Sykiotis, G. P., Maillard, M., Fraga, M., Ribi, C., Kuntzer, T., Michielin, O., Peters, S., Coukos, G., Spertini, F., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30828-3 · Cited by 191
Adenosine and ATP Receptors in the Brain
Burnstock, G., B. Fredholm, B., & Verkhratsky, A. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795347627 · Cited by 190
Snyder, B., Shell, B., Cunningham, J. T., & Cunningham, R. L. (2017) · Physiological Reports · doi:10.14814/phy2.13258 · Cited by 189
“Chronic activation of proinflammatory M1 markers associated with sleep apnea may be a contributing risk factor to neurodegenerative diseases (Lucas et al. 2006; Chao et al. 2014; Monson et al. 2014).”
BackgroundAcosta, S. A., Tajiri, N., Hoover, J., Kaneko, Y., & Borlongan, C. V. (2015) · Stroke · doi:10.1161/strokeaha.115.009854 · Cited by 189
“Cytotoxins induce chronic activation and exacerbation of microglia and antigen-presenting cells (MHCII+) instigating further upregulation of inflammatory mediators, such as tumor necrosis factor-α (TNFα), IL-1β, nitric oxide, and reactive oxygen species causing edema, necrosis, and apoptosis.(51,52) Interestingly, the…”
Background
Metadata
- Authors
- Lucas, S., Rothwell, N. J., & Gibson, R. M.
- Affiliations
- University of Manchester (GB)
- HSE Science and Research Centre (GB)
- Corresponding author
- Rothwell, Nancy J
- ORCID
- Rothwell, Nancy J
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 147
- Issue
- S1
- Pages
- S232-40
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1760754
- OpenAlex
- W1594425991
- Cited by
- 1,272
- References
- 41
- Citations by year
- 2026: 12 · 2025: 37 · 2024: 32 · 2023: 57 · 2022: 65 · 2021: 69 · 2020: 62 · 2019: 80 · 2018: 67 · 2017: 67 · 2016: 60 · 2015: 89 · 2014: 77 · 2013: 79 · 2012: 62
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- neuroinflammation, central nervous system injury, immune privilege, inflammatory cytokines, prostaglandins, free radicals, complement system, chemokines, glial activation, interleukin-1, interleukin-1 receptor antagonist, stroke, traumatic brain injury, Alzheimer's disease, anti-inflammatory therapy, neurodegeneration, aging
- MeSH terms
- Acute Disease, Animals, Brain, Central Nervous System Diseases, Chronic Disease, Craniocerebral Trauma, Humans, Inflammation, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.